Almeida, C.F.; Teixeira, N.; Valente, M.J.; Vinggaard, A.M.; Correia-da-Silva, G.; Amaral, C.
Cannabidiol as a Promising Adjuvant Therapy for Estrogen Receptor-Positive Breast Tumors: Unveiling Its Benefits with Aromatase Inhibitors. Cancers 2023, 15, 2517.
https://doi.org/10.3390/cancers15092517
AMA Style
Almeida CF, Teixeira N, Valente MJ, Vinggaard AM, Correia-da-Silva G, Amaral C.
Cannabidiol as a Promising Adjuvant Therapy for Estrogen Receptor-Positive Breast Tumors: Unveiling Its Benefits with Aromatase Inhibitors. Cancers. 2023; 15(9):2517.
https://doi.org/10.3390/cancers15092517
Chicago/Turabian Style
Almeida, Cristina Ferreira, Natércia Teixeira, Maria João Valente, Anne Marie Vinggaard, Georgina Correia-da-Silva, and Cristina Amaral.
2023. "Cannabidiol as a Promising Adjuvant Therapy for Estrogen Receptor-Positive Breast Tumors: Unveiling Its Benefits with Aromatase Inhibitors" Cancers 15, no. 9: 2517.
https://doi.org/10.3390/cancers15092517
APA Style
Almeida, C. F., Teixeira, N., Valente, M. J., Vinggaard, A. M., Correia-da-Silva, G., & Amaral, C.
(2023). Cannabidiol as a Promising Adjuvant Therapy for Estrogen Receptor-Positive Breast Tumors: Unveiling Its Benefits with Aromatase Inhibitors. Cancers, 15(9), 2517.
https://doi.org/10.3390/cancers15092517